Atlas FDA

VITROS Anti-HBe

FDA premarket approval P100001/S016 · decided 2019-06-19

Approval details

PMA number
P100001
Supplement
S016
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
VITROS Anti-HBe
Generic name
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
Applicant
Ortho-Clinical Diagnostics
Date received
2019-05-21
Decision date
2019-06-19
Days to decision
29 days
Decision code
OK30
Product code
LOM
Advisory committee
Microbiology
Expedited review
No
Location
Rochester, NY
Statement
Establishment of a new Environmental Controlled Area Room at an existing facility.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
VITROS Immunodiagnostic Products Syphilis Reagent Pack (K241534)Ortho Clinical Diagnostics2024-08-28
VITROS Immunodiagnostic Products Total ß-hCG II Reagent Pack (K233581)Ortho Clinical Diagnostics2024-05-08
VITROS Immunodiagnostic Products Intact PTH II Reagent Pack (K221197)Ortho Clinical Diagnostics2023-09-05
VITROS Immunodiagnostic Products CEA Reagent Pack (K231517)Ortho Clinical Diagnostics2023-08-23
VITROS Immunodiagnostic Products CA 19-9TM Reagent Pack (K231525)Ortho Clinical Diagnostics2023-08-09
VITROS Immuodiagnostic Products CA 125 II Reagent Pack (K221355)Ortho Clinical Diagnostics2022-12-12
VITROS AFP (K213626)Ortho Clinical Diagnostics2022-06-15
VITROS Immunodiagnostic Products CK-MB Reagent Pack (K212648)Ortho Clinical Diagnostics2022-01-28